Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5801 USD | +2.15% | +15.47% | +6.77% |
09/05 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.77% | 12Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
+1.48% | 2.23TCr | |
-12.64% | 2.22TCr | |
-5.10% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+7.77% | 1.43TCr | |
+37.41% | 1.25TCr |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Wedbush Analyst Assumes Coverage of Neutral-Rated Sangamo Therapeutics, Adjusts Price Target to $5 From $10, Notes 'Uncertainty Around' SAR445136 Path Forward in Sickle Cell Disease